Effect of renin-angiotensin system inhibitors on prevention of peritoneal fibrosis in peritoneal dialysis patients

被引:29
作者
Jing, Sun [1 ]
Kezhou, Yu [1 ]
Hong, Zhang [1 ]
Qun, Wang [1 ]
Rong, Wang [1 ]
机构
[1] Shandong Univ, Dept Kidney, Shandong Prov Hosp, Jinan 250021, Peoples R China
关键词
peritoneal dialysis; peritoneal fibrosis; renin-angiotensin system; ENDOTHELIAL GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; VASCULAR-PERMEABILITY FACTOR; MESOTHELIAL CELLS; RECEPTOR BLOCKERS; ACE-INHIBITORS; FACTOR-BETA; MEMBRANE; MECHANISMS; GLUCOSE;
D O I
10.1111/j.1440-1797.2009.01162.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim: Long-term peritoneal dialysis (PD) may lead to peritoneal fibrosis and ultrafiltration failure. It had been demonstrated that the renin-angiotensin system (RAS) plays a key role in the regulation of peritoneal function in rats on PD. We investigated the effects of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) on long-term PD patients. Methods: We analyzed data from 66 patients treated with PD therapy at our centre for at least 12 months retrospectively, during which time at least two peritoneal equilibration tests (PET) were performed. Thirty-eight patients were treated with ACE/angiotensin II (AII) inhibitors (ACE/ARB group); the other 28 received none of the above drugs during the entire follow up (control group). The expression of fibronectin, transforming growth factor-beta 1 (TGF-beta 1), Aquaporin1 (AQP1) and vascular endothelial growth factor (VEGF) in the overnight effluent were examined by enzyme-linked immunosorbent assay. Results: The demographic data of the two groups showed no difference during the study. No difference between the groups was found with respect to residual renal function (RRF) at the start for both groups by the end of follow up, decreased in the vast majority of patients from both groups (P = 0.014). After 12 months, a significant difference in ultrafiltration was found between the two groups: in the control group it had decreased, while it had not changed in the ACE/ARB group (P < 0.05). In comparison with the baseline level, expression of fibronectin, TGF-beta 1 and VEGF in dialysate effluent were significantly increased except for AQP1 in the control group (P < 0.05), but not in the ACE/ARB group (P > 0.05). Conclusion: The findings suggest that ACE/AII inhibitors appeared to have a slower rate of decline in ultrafiltration and RRF, effectively protect against peritoneal fibrosis in long-term peritoneal dialysis. Long-term follow up seems to be required to draw more conclusions.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 50 条
  • [31] Renin-angiotensin system inhibitors and angioedema: anesthetic implications
    Stojiljkovic, Ljuba
    CURRENT OPINION IN ANESTHESIOLOGY, 2012, 25 (03) : 356 - 362
  • [32] Strategies for preventing peritoneal fibrosis in peritoneal dialysis patients: new insights based on peritoneal inflammation and angiogenesis
    Zhen Zhang
    Na Jiang
    Zhaohui Ni
    Frontiers of Medicine, 2017, 11 : 349 - 358
  • [33] MiR-200a ameliorates peritoneal fibrosis and functional deterioration in a rat model of peritoneal dialysis
    Wei, Xin
    Bao, Yi
    Zhan, Xiaojiang
    Zhang, Li
    Hao, Guojun
    Zhou, Jing
    Chen, Qinkai
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (05) : 889 - 896
  • [34] Navigating Renin-Angiotensin System Inhibitors in Patients with Declines in eGFR
    Shulman, Rachel
    Cohen, Jordana B.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10): : 1309 - 1311
  • [35] The renin-angiotensin-aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?
    Nessim, Sharon J.
    Perl, Jeffrey
    Bargman, Joanne M.
    KIDNEY INTERNATIONAL, 2010, 78 (01) : 23 - 28
  • [36] Comparative Effectiveness of Renin-Angiotensin System Antagonists in Maintenance Dialysis Patients
    Shirennan, Theresa I.
    Mahnken, Jonathan D.
    Phadnis, Milind A.
    Ellerbeck, Edward F.
    Wetmore, James B.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2016, 41 (06) : 873 - 885
  • [37] The role of the renin-angiotensin system in liver fibrosis
    Munshi, M. Kamruzzman
    Uddin, Mohammad N.
    Glaser, Shannon S.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 236 (05) : 557 - 566
  • [38] Renin-angiotensin system in the pathogenesis of liver fibrosis
    Regina Maria Pereira
    Robson Augusto Souza dos Santos
    Filipi Leles da Costa Dias
    Mauro Martins Teixeira
    Ana Cristina Simoes e Silva
    World Journal of Gastroenterology, 2009, 15 (21) : 2579 - 2586
  • [39] Prevention of malnutrition in peritoneal dialysis patients
    Lobbedez, T
    Pujo, M
    El Haggan, W
    de Ligny, BH
    Levaltier, B
    Ryckelynck, JP
    NEPHROLOGIE, 2003, 24 (07): : 387 - 389
  • [40] Renin-angiotensin system in the pathogenesis of liver fibrosis
    Pereira, Regina Maria
    Souza dos Santos, Robson Augusto
    da Costa Dias, Filipi Leles
    Teixeira, Mauro Martins
    Simoes e Silva, Ana Cristina
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (21) : 2579 - 2586